Related Experiment Video
Updated: Feb 21, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Atherosclerosis: analysis of the eNOS (T786C) gene polymorphism.
A M Barbosa1,2, K S F Silva3, M H Lagares1,2
1Departamento de Biologia, Núcleo de Pesquisas Replicon, , , Brasil.
This study investigated the T786C polymorphism in the eNOS gene and its association with coronary arteriosclerotic disease. The T allele showed a tendency towards association, but results were not statistically significant in the studied population.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Molecular Biology
Background:
- Coronary arteriosclerotic disease is a leading cause of mortality.
- Atherosclerosis involves arterial narrowing and thrombosis, leading to severe clinical events.
- Nitric oxide, regulated by the eNOS gene, plays a crucial role in vascular health.
Purpose of the Study:
- To investigate the association between the T786C polymorphism of the eNOS gene and coronary arteriosclerotic disease.
- To determine if specific genotypes (TT, TC, CC) correlate with the presence of atherosclerosis.
- To analyze the influence of gender and smoking on this potential association.
Main Methods:
- Genotyping of the T786C polymorphism in 297 patients with diagnosed atherosclerotic disease and controls.
- Comparison of genotype frequencies between case and control groups using chi-square and G-tests.
- Stratified analysis based on gender and smoking status.
Main Results:
- The TC genotype was more prevalent in both groups, but without statistical significance.
- No significant differences were observed in genotype distributions (TC/TT vs. CC) between cases and controls.
- Gender and smoking status did not significantly alter the observed genotype associations.
Conclusions:
- The T786C polymorphism of the eNOS gene did not show a statistically significant association with coronary arteriosclerotic disease in this cohort.
- Despite a suggested tendency for the T allele, the study did not confirm a link between this polymorphism and atherosclerosis.
- Further research with larger sample sizes may be needed to clarify the role of eNOS polymorphisms in cardiovascular disease.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

